COVID antibodies in breast milk: What do experts and studies say? wcnc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcnc.com Daily Mail and Mail on Sunday newspapers.
Rebel Wilson reveals fertility struggle in emotional post: I got some bad news today TODAY 3 hrs ago Alexander Kacala
On Sunday night, Rebel Wilson took to Instagram to seemingly open up about an experience unfortunately many people can relate to: fertility struggles. I got some bad news today and didn’t have anyone to share it with. but I guess I gotta tell someone, she said in the caption, paired with a pic of her looking upset against a gorgeous landscape. To all the women out there struggling with fertility, I feel ya. The universe works in mysterious ways and sometimes it all doesn’t make sense. but I hope there’s light about to shine through all the dark clouds.
Anthony DeCarlo / Yale School of Medicine
When Amanda, 28, found out that she was pregnant with her second child, she was in the middle of the COVID-19 pandemic and struggling with opioid use disorder.
“I was pretty heavy into my drug use,” said Amanda, whose last name is being withheld due to patient confidentiality. “I had given up hope and was figuring out a way to use drugs and get away with the consequences. But it doesn’t work like that.”
Now, however, Amanda is feeling “really good.” That’s because she is in a clinical trial for pregnant women run by the Yale School of Medicine, through which she receives medication-assisted treatment (MAT) for her opioid use disorder (OUD). Amanda’s OB-GYN is among a group of physicians at 12 clinics in Connecticut and Massachusetts who are training with Yale to offer OB-GYN care and treatment for substance use disorder under one roof to pregnant patients.
email article
A new combined hormonal contraceptive pill was found to be effective across a wide range of patients, according to data from a phase III trial.
Estetrol/drospirenone (Nextstellis) had high contraceptive efficacy regardless of age group, body mass index (BMI), or prior contraceptive use, reported Mitchell Creinin, MD, of the University of California Davis in Sacramento.
Additionally, unscheduled bleeding occurred in less than a quarter of women, and decreased over time, he said in a presentation at the American College of Obstetricians and Gynecologists (ACOG) virtual meeting.
Estetrol (E4) is a native estrogen produced by the human fetal liver. Its unique characteristics result in selective activity in tissue, and in combination with drospirenone, it suppresses ovulation while having minimal impact on hormone-binding globulins, lipids, endocrine parameters, and hemostatic parameters.